MTOR and prostate carcinoma: Dysregulation of the phosphatidylinositol 3-kinase (PI3K)/AKT (AKT serine/threonine kinase)/mammalian target of rapamycin (mTOR) signalling pathway is linked to the progression of prostate cancer.